How big is MoonLake Immunotherapeutics?

Jun 22 2025 06:22 PM IST
share
Share Via
As of Jun 18, MoonLake Immunotherapeutics has a market capitalization of 2,760.75 million, categorizing it as a Small Cap company. As of Dec 24, Shareholder's Funds are 446.83 million and Total Assets are 477.93 million, with net sales of 0.00 million and a net profit of -147.83 million for the latest four quarters.
As of Jun 18, MoonLake Immunotherapeutics has a market capitalization of 2,760.75 million, categorizing it as a Small Cap company.

As of Jun 24, the sum of Net Sales for the latest four quarters is 0.00 million, while the sum of Net Profit for the same period is -147.83 million.

As of Dec 24, the reporting period shows Shareholder's Funds at 446.83 million and Total Assets at 477.93 million.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News